PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 90-95% of Healthcare median of 63.43. John Neff would demand higher returns to compensate for below-average ESG risk management.
59.54
Environmental score near Healthcare median of 59.76. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
58.66
Social score 80-90% of Healthcare median of 66.36. Martin Whitman would look for hidden social liabilities and reputational risks.
57.40
Governance score 80-90% of Healthcare median of 64.48. Martin Whitman would look for hidden agency costs and management entrenchment risks.